New acquisition techniques: Fields of application

Abdominal Imaging

Volumn 37, Issue 2, 2012, Pages 155-163

  Van Beers, Bernard E ^a   Doblas, Sabrina ^a   Sinkus, Ralph ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

Diffuse liver disease; Diffusion weighted MR imaging; Dynamic contrastenhanced MR imaging; Liver MR imaging; Liver tumors; MR elastography

Indexed keywords

GADOXETIC ACID;

ARTICLE; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; ELASTOGRAPHY; HUMAN; IMAGE ANALYSIS; INFORMATION PROCESSING; LIVER CELL CARCINOMA; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; LIVER TUMOR; MAGNETIC RESONANCE ELASTOGRAPHY; MATHEMATICAL ANALYSIS; MEASUREMENT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIOLOGICAL PROCEDURES; REPRODUCIBILITY; STANDARDIZATION; TIME RESOLVED DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ELASTICITY IMAGING TECHNIQUES; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LIVER DISEASES; MAGNETIC RESONANCE IMAGING; TIME FACTORS;

EID: 84863726306     PISSN: 09428925     EISSN: 14320509     Source Type: Journal    
DOI: 10.1007/s00261-011-9748-3     Document Type: Article

References (81)

1. Taouli B, Koh DM (2010) Diffusion-weighted MR imaging of the liver. Radiology 254:47-66
2. Lewin M, Poujol-Robert A, Boëlle PY, et al. (2007) Diffusionweighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C. Hepatology 46:655-658
3. Le Bihan D, Breton E, Lallemand D, et al. (1988) Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 168:497-505
4. Luciani A, Vignaud A, Cavet M, et al. (2008) Liver cirrhosis: intravoxel incoherent motion MR imaging. Radiology 249:891-899
5. Padhani A, Liu G, Koh DM, et al. (2009) Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia 11:102-125
6. Ivancevic MK, Kwee TC, Takahara T, et al. (2009) Diffusionweighted MR imaging of the liver at 3.0 Tesla using tracking only navigator echo (TRON): a feasibility study. J Magn Reson Imaging 30:1027-1033
7. Kwee TC, Takahara T, Koh DM, Nievelstein R, Luijten P (2008) Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free-breathing diffusion-weighted MR imaging of the liver. J Magn Reson Imaging 28:1141-1148
8. Kim S, Lee S, Byun J, et al. (2010) Malignant hepatic tumors: short-term reproducibility of apparent diffusion coefficients with breath-hold and respiratory-triggered diffusion-weighted MR imaging. Radiology 255:815-823
9. Taouli B, Sandberg A, Stemmer A, et al. (2009) Diffusion-weighted imaging of the liver: comparison of navigator triggered and breathhold acquisitions. J Magn Reson Imaging 30:561-568
10. Van den Bos I, Hussain S, Krestin G, Wielopolski P (2008) Liver imaging at 3.0 T: diffusion-induced black-blood echo-planar imaging with large anatomic volumetric coverage as an alternative for specific absorption rate-intensive echo-train spin-echo sequences: feasibility study. Radiology 248:264-270
11. Sheihmorteza M, Sirlin C, Wolfon T, et al. (2009) Effect of shot number on the calculated apparent diffusion coefficient in phantoms and in human liver in diffusion-weighted echo-planar imaging. J Magn Reson Imaging 30:547-553
12. Kwee T, Takahara T, Niwa T, et al. (2009) Influence of cardiac motion on diffusion-weighted magnetic resonance imaging of the liver. Magn Reson Mater Phy 22:319-325
13. Mürtz P, Flacke S, Träber F, et al. (2002) Abdomen: diffusionweighted MR imaging with pulse-triggered single-shot sequences. Radiology 224:258-264 (Pubitemid 34680404)
14. Doblas S, Wagner M, Daire JL, et al. (2011) Repeatability of perfusion and pure diffusion parameters in a bi-exponential, multib diffusion imaging approach. ISMRM, abstract 1061
15. Taouli B, Chouli M, Martin AJ, et al. (2008) Chronic hepatitis: role of diffusion-weighted imaging and diffusion tensor imaging for the diagnosis of liver fibrosis and inflammation. J Magn Reson Imaging 28:89-95 (Pubitemid 351956470)
16. Annet L, Peeters F, Abarca-Quinones J, et al. (2007) Assessment of diffusion-weighted MR imaging in liver fibrosis. J Magn Reson Imaging 25:122-128 (Pubitemid 46098861)
17. Coenegrachts K, De Geeter F, Ter Beek L, et al. (2009) Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Eur Radiol 19:370-379
18. Hussain S, De Becker J, Hop W, Dwarkasing S, Wielopolski P (2005) Can a single-shot black-blood T2-weighted spin-echo echoplanar imaging sequence with sensitivity encoding replace the respiratory-triggered turbo spin-echo sequence for the liver? An optimization and feasibility study. J Magn Reson Imaging 21:219-229 (Pubitemid 40280115)
19. Nasu K, Kuroki Y, Nawano S, et al. (2006) Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology 239:122-130
20. Goshima S, Kanematsu M, Kondo H, et al. (2008) Diffusionweighted imaging of the liver: optimizing b value for the detection and characterization of benign and malignant hepatics lesions. J Magn Reson Imaging 28:691-697
21. Taouli B, Vilgrain V, Dumont E, et al. (2003) Evaluation of liver diffusion isotropy and characterization of focal hepatic lesions with two single-shot echo-planar MR imaging sequences: prospective study in 66 patients. Radiology 226:71-78 (Pubitemid 36163910)
22. Parikh T, Drew SJ, Lee V, et al. (2008) Focal liver lesion detection and characterization with diffusion-weighted MR imaging: comparison with standard breath-hold T2-weighted imaging. Radiology 246:812-822
23. Bruegel M, Holzapfel K, Gaa J, et al. (2008) Characterization of focal liver lesions by ADC measurements using a respiratory triggered diffusion-weighted single-shot echo-planar MR imaging technique. Eur Radiol 18:477-485 (Pubitemid 351248179)
24. Annet L, Duprez T, Grandin C, et al. (2002) Apparent diffusion coefficient measurements within intracranial epidermoid cyst in six patients. Neuroradiology 44:326-328 (Pubitemid 36097178)
25. Doblas S, Wagner M, Daire JL, et al. (2011) The added value of a bi-exponential approach for processing multi-b diffusion-weighted imaging data in the diagnosis of hepatic tumors. ISMRM, abstract 1062
26. Moffat BA, Chenevert TL, Laurence TS, et al. (2005) Functional diffusion map: a non-invasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA 102:5524-5529 (Pubitemid 40530291)
27. Moffat BA, Hall DE, Stojanovska J, et al. (2004) Diffusion imaging for evaluation of tumor therapies in preclinical animal models. Magn Reson Mater Phy 17:249-259 (Pubitemid 40362308)
28. Lewin M, Fartoux L, Vignaud A, et al. (2011) The diffusionweighted imaging perfusion fraction f is a potential marker of sorafenib treatment in advanced hepatocellular carcinoma: a pilot study. Eur Radiol 21:281-290
29. Wagner M, Doblas S, Daire JL, et al. (2001) Diffusion-weighted MRI for the zonal characterization of livers tumors. ISMRM, abstract 2987
30. Llovet JM, Di Bisceglie AM, Bruix J, et al. (2008) Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst 100:698-711
31. Rubbia-Brandt L, Gisotra E, Brezault C, et al. (2007) Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neoadjuvant chemotherapy followed by liver surgery. Ann Oncol 18:299-304 (Pubitemid 46323097)
32. Blazer D, Kishi Y, Maru D, et al. (2008) Pathologic response to preoperative chemotherapy: a new outcome end point after resection of hepatic colorectal metastases. J Clin Oncol 25:5344-5351
33. Chun Y, Vauthey JN, Boonsirikamchai P, et al. (2009) Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases. JAMA 302:2338-2344
34. Muthupillai R, Lomas D, Rossman J, et al. (1995) Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269:1854-1857
35. Sinkus R, Tanter M, Xydeas T, et al. (2005) Viscoelastic shear properties of in vivo breast lesions measured by MR elastography. Magn Reson Imaging 23:159-165
36. Huwart L, Sempoux C, Vicaut E, et al. (2008) Magnetic resonance elastography for the non-invasive staging of liver fibrosis. Gastroenterology 135:299-302
37. Huwart L, Peeters F, Sinkus R, et al. (2006) Liver fibrosis: non-invasive assessment withMR elastography. NMR Biomed 19:173-179
38. Huwart L, Sempoux C, Salameh N, et al. (2007) Liver fibrosis: noninvasive assessment with MR elastography versus aspartate aminotransferase-to-platelet ration index. Radiology 245:458-466 (Pubitemid 47612527)
39. Yin M, Talwalkar JA, Glaser KJ, et al. (2007) Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastrorenterol Hepatol 5:1207-1213
40. Asbach P, Klatt D, Schlosser B, et al. (2010) Viscoelasticity-based staging of hepatic fibrosis with multifrequency MR elastography. Radiology 257:80-86
41. Salameh N, Peeters F, Sinkus R, et al. (2007) Hepatic viscoelastic parameters measured with MR elastography: correlations with quantitative analysis of liver fibrosis in the rat. J Magn Reson Imaging 26:956-962 (Pubitemid 47548156)
42. Garcia-Tsao G, Friedman S, Iredale J, PinzaniM(2010) Now there are many (stages) where before there was one: in search of a pathophysiological classification of cirrhosis. Hepatology 51:1-5
43. Castera L, Pinzani M (2010) Biopsy and non-invasive methods for the diagnosis of liver fibrosis: does it take two to tango? Gut 59: 861-866
44. Coco B, Oliveri F, Maina AM, et al. (2007) Transient elastography: a new surrogate marker of liver fibrosis influenced by major changes of transaminases. J Viral Hepat 14:360-369 (Pubitemid 46587854)
45. Salameh N, Larrat B, Abarca-Quinones J, et al. (2009) Early detection of steatohepatitis in fatty rat liver by using MR elastography. Radiology 253:90-97
46. Venkatesh SK, Yin M, Glockner JF, et al. (2008) MR elastography of liver tumors: preliminary results. AJR Am J Roentgenol 190: 1534-1540 (Pubitemid 351798532)
47. Doblas S, Garteiser P, Haddad N, et al. (2011) Magnetic resonance elastography measurements of viscosity: a novel biomarker for human hepatic tumor malignancy? ISMRM, abstract 389
48. Papazoglou S, Xu C, Hamhaber U, et al. (2009) Scatter-based magnetic resonance elastography. Phys Med Biol 7:2229-2241
49. Sinkus R, Siegmann K, Xydeas T, et al. (2007) MR elastography of breast lesions: understanding the solid/liquid duality can improve the specificity of contrast-enhanced MR mammography. Magn Reson Med 58:1135-1144 (Pubitemid 350234200)
50. Materne R, Hormans Y, Jamart J, et al. (2000) Gadolinium-enhanced arterial-phase MR imaging of hypervascular livers tumors: comparison between tailored and fixed scanning delays in the same patients. J Magn Reson Imaging 11:244-249 (Pubitemid 30127692)
51. Beck G, De Becker J, Jones A, et al. (2008) Contrast-enhanced timing robust acquisition order with a preparation of the longitudinal signal component (CENTRA plus) for the 3D contrast-enhanced abdominal imaging. J Magn Reson Imaging 27:1461-1467 (Pubitemid 351770704)
52. Walker-Samuel S, Leach M, Collins D (2006) Evaluation of response to treatment using DCE-MRI: the relationship between initial area under the gadolinium curve (IAUGC) and quantitative pharmacokinetic analysis. Phys Med Biol 51:3593-3602 (Pubitemid 44026420)
53. Materne R, Smith AM, Dehoux JP, et al. (2002) Assessment of hepatic perfusion parameters with dynamic MRI. Magn Reson Med 47:135-142 (Pubitemid 34019702)
54. Evelhoch J (1999) Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 10:254-259 (Pubitemid 29463107)
55. Hagiwara M, Rusinek H, Lee V, et al. (2008) Advanced liver fibrosis: diagnosis with 3D whole-liver perfusion MR imaging-initial experience. Radiology 246:926-934
56. Tofts P, Brix G, Buckley D, et al. (1999) Estimating kinetic parameters from dynamic contrast-enhanced T1-weighted MRI of a diffusible tracer: standardized quantities and symbols. J Magn Reson Imaging 10:223-232 (Pubitemid 29463104)
57. Liu Y, Matsui O (2007) Changes of intratumoral microvessels and blood perfusion during establishment of hepatic metastases in mice. Radiology 243:386-395 (Pubitemid 46649693)
58. International Consensus Group for Hepatocellular Neoplasia (2009) Pathologic diagnosis of early of hepatocellular carcinoma: a report of the international consensus group for hepatocellular neoplasia. Hepatology 49:658-664
59. Buckley D (2002) Uncertainty in the analysis of tracer kinetics using dynamic contrast-enhanced T1-weighted MRI. Magn Reson Med 47:601-606 (Pubitemid 34194016)
60. Michoux N, Huwart L, Abarca-Quinones J, et al. (2008) Transvascular and interstitial transport in rat hepatocellular carcinomas: dynamic contrast-enhanced MRI assessment with low and highmolecular weight agents. J Magn Reson Imaging 28:906-914
61. Leach M, Brindle K, Evelhoch J, et al. (2005) The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 92:1599-1610 (Pubitemid 40756468)
62. Koh T, Thong C, Lee P, et al. (2008) Hepatic metastases: in vivo assessment of parameters at dynamic contrast-enhanced MR imaging with dual-input two-compartment kinetics model. Radiology 249:307-320
63. Galbraith S, Lodge M, Taylor J, et al. (2002) Reproducibility of dynamic contrast-enhanced MRI in human muscle and tumors: comparison of quantitative and semi-quantitative analysis. NMR Biomed 15:132-142 (Pubitemid 34213403)
64. Padhani A, Hayes C, Landau S, LeachM (2002) Reproducibility of quantitative dynamic MRI of normal human tissues. NMR Biomed 15:143-153 (Pubitemid 34213404)
65. Thabut D, Shah V (2010) Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension? J Hepatol 53:976-980
66. Annet L, Materne R, Danse E, et al. (2003) Hepatic flow parameters measured with MR imaging and Doppler US: correlations with degree of cirrhosis and portal hypertension. Radiology 229:409-414 (Pubitemid 37310826)
67. Van Beers BE, Materne R, Annet L, et al. (2003) Capillarization of the sinusoids in liver fibrosis: noninvasive assessment with contrastenhanced MRI in the rabbit. Magn Reson Med 49:692-699 (Pubitemid 36389979)
68. Ronot M, Asselah T, Paradis V, et al. (2010) Liver fibrosis in chronic hepatitis C virus infection: differentiating minimal from intermediate fibrosis with perfusion CT. Radiology 256:135-142
69. Takahashi N, Yoshioka H, Yamaguchi M, Saida Y, Itai Y (2003) Accelerated dynamic MR imaging with a parallel imaging technique for hypervascular hepatocellular carcinomas: usefulness of a test bolus in examination and subtraction imaging. J Magn Reson Imaging 18:80-89 (Pubitemid 36791272)
70. Cuenod C, Leconte I, Siauve N, et al. (2001) Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 218:556-561 (Pubitemid 32121075)
71. White M, O'Gorman R, Charles-Edwards E, et al. (2007) Parametric mapping of the hepatic perfusion index with gadoliniumenhanced volumetric MRI. Br J Radiol 80:113-120 (Pubitemid 46951254)
72. Zechman C, Woenne E, Brix G, et al. (2007) Impact of stroma on the growth, microcirculation, and metabolism of experimental prostate tumors. Neoplasia 9:57-59
73. Hlatky L, Hahnfeldt P, Folkman J (2002) Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. J Natl Cancer Inst 94:883-893 (Pubitemid 34778087)
74. D'Assignies G, Couvelard A, Bahrami S, et al. (2009) Pancreatic endocrine tumors: tumor blood flow assessed with perfusion CT reflects angiogenesis and correlates with prognostic factors. Radiology 250:407-416
75. Baish J, Netti P, Jain R (1997) Transmural coupling of fluid flow in microcirculatory network and interstitium in tumors. Microvasc Res 53:128-141 (Pubitemid 27202429)
76. Lee L, Sharma S, Morgan B, et al. (2006) Biomarkers for assessment of pharmacologic activity for a vascular endothelial growth factor (VEGF) receptor inhibitor, PTK787/ZK 222584 (PTK/ZK): translation of biological activity in a mouse melanoma metastasis model to phase I studies in patients with advanced colorectal cancer with liver metastases. Cancer Chemother Pharmacol 57:761-771
77. Morgan B, Thomas A, Drevs J, et al. (2003) Dynamic contrastenhanced magnetic resonance imaging as a biomarker for the pharmacological response of PTK787/ZK 222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinases, in patients with advanced colorectal cancer and liver metastases: results from two phase I studies. J Clin Oncol 21:3955-3964 (Pubitemid 46606209)
78. Tong R, Boucher Y, Kosin S, et al. (2004) Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors. Cancer Res 64:3731-3736 (Pubitemid 38697278)
79. Mc Donald D, Choyke P (2003) Imaging of angiogenesis: from microscope to clinic. Nat Med 9:713-725 (Pubitemid 36749220)
80. Inai T, Mancuso M, Hashizume H (2004) Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts. Am J Pathol 165:35-52 (Pubitemid 38821812)
81. Ansiaux R, Baudelet C, Jordan B, et al. (2005) Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin Cancer Res 11:743-750 (Pubitemid 40116903)